Meet us while attending
The Liver Meeting®

The Liver Meeting® 2021

November 12 - 15 |

Virtual Conference

00 days 00 hours 00 minutes 00 seconds
Visit our virtual booth

The Liver Meeting® brings together clinicians, associates, and scientists from around the world to exchange information on the latest research, discuss new developments in liver treatment and transplantation, and network with leading experts in the field of hepatology.

Cutting-edge research, top-notch experts, and thousands of posters, all at your fingertips. The Liver Meeting Digital Experience gives you access to the specialty’s best science no matter where you are.

We will be exhibiting at The Liver Meeting Digital Experience 2021 on the AASLD virtual platform - make sure you stop by and meet the team!

Below you will find intro videos for our products, a number of resource materials, and of course our lovely team, who are available for meetings where you can ask any questions you may have or just get to know us a little better.

Talk to one of our experts

If you'd like more information on Perspectum or a specific product, please get in touch with one of the experts from our team.

Featured Abstracts

Poster | Available Throughout

Reference ranges for biliary system measurements in paediatrics using Quantitative MRCP

Cheng L, Telford A, Ferreira C, Dennis A, Mavar M, Thomaides-Brears H, Kelly M, Banerjee R

Poster | Available Throughout

Health Related Quality of Life in Adults with Non-Alcoholic Fatty Liver Disease: Baseline Data from a multi-national clinical trial involving four European jurisdictions

Carolan J, Telford A, Dennis, A, Lorgelly, P

Poster | Available Throughout

High prevalence of multi-organ steatosis and fibroinflammation, identified by multi-parametric MRI, in people with type 2 diabetes

Telford A, Gibbons K, Hamid A, Deelchand V, Woolgar J, Suriano R, Thomaides-Brears H, Banerjee R, Kemp G, Ali S, Thanabalasingham G, Cuthbertson D

Liver fibro-inflammation heterogeneity measured using cT1 interquartile range has utility to distinguish between different liver diseases

Shumbayawonda E, Beyer C, Pantoja C, Thomaides-Brears H, Socha P, Culver E, Hirschfield G, Fallowfield J, Pavlides M, Banerjee R, Noureddin M 

Quantitative MR can identify paediatric patients with quiescent autoimmune disease who may benefit from a change in treatment

Shumbayawonda1 E, Janowski K, Dennis A, Thomaides-Brears H, Kelly M, Pronicki M, Grajkowska W, Wozniak M, Pawliszak P, Jurkiewicz E, Banerjee R, Socha P

Poster | Available Throughout

Quantitative assessment of histopathological cardinal features of non-alcoholic fatty liver disease using machine learning

Langford, C., Roy, A., Goldfinger, M., Olchanyi, M., Ritter, D., Bogush, A., Kazimianec, A., Irving, B., Kendall, TJ., Fryer, E., Goldin, R., Brady, JM., Banerjee, R., Fleming, K.  

Poster | Available Throughout

Elevated visceral and liver fat significantly increase risk of hospitalisation following COVID-19 infection

Waddell, T., Roca-Fernandez, A., McGonigle, J., Jandor A., Carapella, V., Thomaides-Brears, H., Dennis, A., Brady, M., Banerjee, R

Poster | Available Throughout

Determining the key features of biliary anatomy in quantitative MRCP for identifying patients with PSC

Are Vijay, Telford A, Dennis A, Cheng L, Langford C, Shumbayawonda E, Kazimianec A, Hirschfield G, Trivedi P, Mavar M, Kelly M, Chalasani N, Akisik F, Banerjee R, Vuppalanchi R

Poster | Available Throughout

cTAG can identify at-risk NASH patients in a NAFLD population: composite biomarker validation study

Kazimianec A, Dennis A, Kelly M, Banerjee R, Imajo, K, Nakajima, A, Harrison, S

Poster | Available Throughout

Imaging biomarker of fibroinflammation in combination with BMI and age predicts metabolic disease status

Kazimianec A, Kin S, Thomaides-Brears H, Chin C, Banerjee R

Poster | Available Throughout

Prospective Assessment of Liver Health Following Liver Resection and Y-90 Radioembolization in Patients with Hepatocellular Carcinoma Using Multi-Parametric MRI Platform

Fichera A, Connell J, Nunez L, Pickels E, Seah S, Ng David CE, Gogna A, Goh Brian KP, Tai David WM, Toh Han Chong, Choo Su Pin, Chan Wan Ying, Hennedige T, Tan Iain BH, Lo RHG, Yan SXX, Chua C, Koo SL, Lim TKH, AL J, Chua SH, Thng CH, Banerjee R, Brady JM, Kelly M, Chow PKH

Poster | Available Throughout

Liver-distributed FXR Agonist TERN-101 Leads to Corrected T1 (cT1) Response and a Population Shift to Lower cT1 Risk Categories in NASH Phase 2a LIFT Study

Eric Lawitz, Rohit Loomba, Kris Kowdley, Matt Kelly, Andrea Dennis, Vidhya Kumar, Rajarshi Banerjee, Diana Chung, Tonya Marmon, Christopher Jones, Erin Quirk, Daria B. Crittenden

Perspectum

Perspectum is a global expert in medical image analysis and software development with specialised imaging CRO capabilities for the identification and monitoring of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), inflammatory bowel disease (IBD), cancer, and type 2 diabetes.

Our mission is to improve the lives of patients by accelerating drug development with smart imaging technology. We want to fundamentally change clinical trials by using multi-parametric magnetic resonance imaging (mpMRI) to offer non-invasive, quantitative biomarkers that are standardised and accurate. This gives sponsors the enhanced data they need accurately detect early efficacy signals, reliably monitor patient response to treatment over time, and improve screening and stratification strategies to lower enrollment costs.

Get to know our products

LiverMultiScan

Learn more

MRCP+

Learn more

Resources

 

Below you can find links to download all of our key resources that would be available to you if you were to visit our exhibition booth. If you have any questions or would like a specific resource, that you're unable to find below, please get in touch.

LiverMultiScan

LiverMultiScan Overview

Download

LiverMultiScan US Clinical Brief

Download

MRCP+

MRCP+ Overview

Download

MRCP+ Whitepaper

Download

Pharma Solutions

Pharma Solutions Overview

Download

Phase 3 Pricing - NASH Clinical Trials

Download

Pharma Capabilities Overview

Download